Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Functional Unit Behavioral Medicine, Function Area Medical Psychology, Karolinska University Hospital, Stockholm, Sweden.
Pain Med. 2021 Feb 23;22(2):315-328. doi: 10.1093/pm/pnaa360.
Acceptance and commitment therapy (ACT) is a behavioral health intervention with strong empirical support for chronic pain but, to date, widespread dissemination is limited. Digital solutions improve access to care and can be integrated into patients' everyday lives.
ACTsmart, a guided smartphone-delivered ACT intervention, was developed to improve the accessibility of an evidence-based behavioral treatment for chronic pain. In the present study, we evaluated the preliminary efficacy of ACTsmart in adults with chronic pain.
The study was an open-label pilot trial. The treatment lasted for 8 weeks, and participants completed all outcome measures at pretreatment and posttreatment and at 3-, 6-, and 12-month follow-ups, with weekly assessments of selected measures during treatment. The primary outcome was pain interference. The secondary outcomes were psychological flexibility, values, insomnia, anxiety, depressive symptoms, health-related quality of life, and pain intensity. All outcomes were analyzed using linear mixed-effects models.
The sample consisted of 34 adults (88% women) with long-standing chronic pain (M=20.4 years, SD=11.7). Compliance to treatment was high, and at the end of treatment, we observed a significant improvement in the primary outcome of pain interference (d = -1.01). All secondary outcomes significantly improved from pretreatment to posttreatment with small to large effect sizes. Improvements were maintained throughout 12 months of follow-up.
The results of this pilot study provide preliminary support for ACTsmart as an accessible and effective behavioral health treatment for adults with chronic pain and warrant a randomized controlled trial to further evaluate the efficacy of the intervention.
接纳与承诺疗法(ACT)是一种行为健康干预方法,对慢性疼痛具有强有力的实证支持,但迄今为止,其广泛传播仍受到限制。数字解决方案可改善获得护理的机会,并可融入患者的日常生活中。
ACTsmart 是一种基于智能手机的指导型 ACT 干预措施,旨在提高一种基于证据的慢性疼痛行为治疗方法的可及性。在本研究中,我们评估了 ACTsmart 在慢性疼痛成人患者中的初步疗效。
这是一项开放标签的试点试验。治疗持续 8 周,参与者在治疗前、治疗后以及 3、6 和 12 个月的随访时完成所有结局测量,并在治疗期间每周评估部分特定测量。主要结局为疼痛干扰。次要结局为心理灵活性、价值观、失眠、焦虑、抑郁症状、健康相关生活质量和疼痛强度。所有结局均采用线性混合效应模型进行分析。
该样本由 34 名长期慢性疼痛患者(88%为女性)组成(M=20.4 年,SD=11.7)。治疗的依从性很高,在治疗结束时,我们观察到疼痛干扰的主要结局显著改善(d=-1.01)。从治疗前到治疗后,所有次要结局均显著改善,且具有小至大的效应量。在 12 个月的随访期间,改善情况得以维持。
这项试点研究的结果初步支持 ACTsmart 作为一种方便获取且有效的行为健康治疗方法,适用于慢性疼痛的成人患者,需要进一步开展随机对照试验来评估该干预措施的疗效。